Does anyone have a policy on using expired medications for code blue simulation that they could share?

Thank you in advance!

Hello,

We have various IV locks built into our EMR. There is some debate of what the scheduled route nomenclature should be. Suggested nomenclature included "IV Dwell" and "IV lock".

What nomenclature does your EMR use?

Thanks in advance for your response!

Hello,

We are in the process of increasing and promoting the correct use of carpuject holders as indicated by the ISMP IV Push guidelines. A question has come up about infection control techniques. How does your facility use carpuject holders? Each nurse has their own and cleans with alcohol? Autoclaves? or patient specific? other?

Thank you in advance for your response.

Hoping that others could share what (if any) changes have been made for ketamine storage/dispensing in response to a reported fatal medication error. http://vtdigger.org/2015/07/09/patient-death-after-ketamine-overdose-lea...

1. Have you removed ketamine from Omnicell/Pyxis?

2. Have you removed ketamine from emergency kits/intubation trays?

3. If yes, was anything added to the emergency kit/intubation tray as a substitute.

Would anyone currently running anticoagulation clinics and utilizing Epic be willing to share some decision support that you have implemented to help guide the providers to utilize modules? Thank you in advance!

Hello,
I am new to my role as Medicationa Safety Officer and I find this forum so helpful. I am reviewing our Mag. Sulfate process for Preeclampsia and Eclampsia and HTN crisis. With that said, does anyone have a best practice they follow? Would an order set be helpful to have? (We have hospitalist that may respond to rapid response team IF OB/GYN Physician not immediately avaialble). I have reviewed what ACOG practice guidelines.
I am interested to learn what other organizations are doing.
Thanks

I wanted to ask how organizations are handling orders for SGLT2 Inhibitors for inpatient use in light of the drug safety communication from May 2015 regarding the risk of ketoacidosis that can present atypically. The agents are non-formulary at our institution. However, should an MD order an SGLT2 inhibitor, we are encouraging pharmacists to have a discussion with prescribers about alternatives and use clinical discretion. This includes discontinuing the mediation if a patient presents with DKA symptoms.

Hello,
I would like to get some feedback for the group.

Do any institutions have issues of not being able to fit all their medications in their automated dispensing cabinets on the floors? If so how do you handle this specifically looking at controlled substances.

Do you always keep the controlled substances in the ADT? Do any institutions utilize "narcotic boxes" or other locked cabinet on the floors or do you always keep your controlled substances in the ADT and allow non controlled substances to overflow into another cabinet?

We have been a no insulin pen health system for quite some time. We are receiving many requests for the use of Toujeo, which only comes in a pen. Has anyone, who is historically a non-insulin pen hospital/system, allowed use of this product? If so, what safety precautions have you put in place? Also if not, how have you prevented errors with conversions of doses? Thanks in advance!

For purposes of eMARS, does your organization use sliding scale insulin as PRN or SCH? Has ISMP weighed in on this issue? If you use scheduled, have you seen any medication errors involving patient receiving unwarranted SSI?

THanks for your help,
Emily Spiceland